<?xml version="1.0" encoding="UTF-8"?><template xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template" xmlns:uuid="java:java.util.UUID"><id>8532fe65-5c71-487b-9218-7dea82a73f7d</id><name>PHARM DOXOrubicin, pegylated liposomal (CAELYX) injection Order</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose>For ordering a(n) DOXOrubicin, pegylated liposomal (CAELYX) injection</purpose><use/><misuse/></details><other_details><item><key>MetaDataSet:Sample Set </key><value>Template metadata sample set </value></item><item><key>Acknowledgements</key><value/></item><item><key>Business Process Level</key><value/></item><item><key>Care setting</key><value/></item><item><key>Client group</key><value/></item><item><key>Clinical Record Element</key><value/></item><item><key>Copyright</key><value/></item><item><key>Issues</key><value/></item><item><key>Owner</key><value/></item><item><key>Sign off</key><value/></item><item><key>Speciality</key><value/></item><item><key>User roles</key><value/></item></other_details></description><annotations path="[openEHR-EHR-INSTRUCTION.service_request.v1]"><items><item><key>Technical.ï»© Technical Traceabililty</key><value>{~AHSID~8532fe65-5c71-487b-9218-7dea82a73f7d~NAME~PHARM DOXOrubicin, pegylated liposomal (CAELYX) injection Order}</value></item><item><key>Pharmacy.AHS Formulary Status</key><value>Formulary</value></item><item><key>Pharmacy.Brand Name</key><value>CAELYX</value></item><item><key>Pharmacy.AHS Formulary Status</key><value>Formulary</value></item><item><key>Pharmacy.Brand Name</key><value>CAELYX</value></item><item><key>Pharmacy.Ordering Clinician Instructions</key><value>MAX Lifetime IV DOXOrubicin, liposomal Dose not established, but is suggested to follow recommendations for regular DOXOrubicin formulation: a) No risk factors: 550 mg/m2/dose. b) Concurrent radiation therapy; previous or concurrent use of cyclophosphamide, anthracyclines or other cardiotoxic drugs: 450 mg/m2/dose.</value></item><item><key>Pharmacy.Drug Administration (nursing)</key><value>Doses less than 90 mg provided in 250 mL of D5W. Doses of 90 mg or greater provided in 500 mL of D5W.</value></item><item><key>Pharmacy.High Alert Medication</key><value>High-alert Medication</value></item><item><key>Pharmacy.Parenteral Drug Monograph</key><value>https://webappsint.albertahealthservices.ca/pharmacy/pm/pm_index.asp?drug=generic</value></item><item><key>Pharmacy.Synonyms</key><value>CAELYX; DOXOrubicin, pegylated liposomal; DOXOrubicin; doxorubicin</value></item><item><key>Pharmacy.AHFS Code</key><value>10:00</value></item><item><key>Pharmacy.AHFS Name</key><value>Antineoplastic Agents</value></item><item><key>Pharmacy.ATC Code</key><value>L01DB01</value></item><item><key>Pharmacy.ATC Name</key><value>ANTINEOPLASTIC AGENTS, CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES</value></item><item><key>Pharmacy.DIN</key><value>02238389</value></item><item><key>Pharmacy.IDC/Co-sign</key><value>Independent check required for oncology indications, refer to local department policy requirements for all other indications</value></item><item><key>Pharmacy.Therapeutic Category 1</key><value>Oncology</value></item><item><key>Pharmacy.Instructions</key><value>MAX Lifetime IV DOXOrubicin, liposomal Dose not established, but is suggested to follow recommendations for regular DOXOrubicin formulation: a) No risk factors: 550 mg/m2/dose. b) Concurrent radiation therapy; previous or concurrent use of cyclophosphamide, anthracyclines or other cardiotoxic drugs: 450 mg/m2/dose.</value></item></items></annotations><definition xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" concept_name="Service request" max="1" name="DOXOrubicin, pegylated liposomal (CAELYX) injection"><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Strength Available"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>2 mg/mL</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Volume"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>10 mL</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Generic Name"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>DOXOrubicin, pegylated liposomal (CAELYX)</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Dosage Form"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>inj VIAL</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Chemo IV Solution"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>D5W</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0156]/description[at0157]/items[at0158]" name="Lifetime Dose"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>YES</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Orderable Name"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>DOXOrubicin, pegylated liposomal (CAELYX) injection</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Dose and Units"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>20 mg/m2/dose</includedValues><includedValues>30 mg/m2/dose</includedValues><includedValues>40 mg/m2/dose</includedValues><includedValues>50 mg/m2/dose</includedValues><includedValues>60 mg/m2/dose</includedValues><includedValues>80 mg/m2/dose</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Route"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>IV</includedValues><includedValues>other - see admin instructions</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Frequency"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues>once</includedValues></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Frequency Clarifier"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"/></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Duration"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues/></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Start Date/Time"><Rule path="/items[at0002]" default=""/></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Stop Date/Time"><Rule path="/items[at0002]" default=""/></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Physician Instructions"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"><includedValues/></constraint></Rule></Items><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1" concept_name="Service request information" max="1" path="/activities[at0001]/description[at0009]/items[at0132]" name="Priority"><Rule path="/items[at0002]"><constraint xsi:type="textConstraint"/></Rule></Items></definition><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1"><digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest></integrity_checks><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1"><digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest></integrity_checks></template>